UTAS chooses ADI Blackfin processors for patient monitoring and
diagnostics devices
2 October 2009
Patient monitoring and diagnostics device manufacturer UTAS has
selected Analog Devices' Blackfin processors to ensure high-performance
digital signal processing operations and robust functionality across its
full line of products.
Leveraging Blackfin’s performance, low power consumption and flexible
peripheral connectivity alongside complementary precision analogue
components also from ADI, UTAS achieved high-performance operations and
a seamlessly connected signal chain in a cost effective, compact system
package.
“Medical professionals depend on UTAS’ equipment to get a clear view
of patient data, which enables them to make timely, more informed
patient care decisions,” said Valeriy Tkachenko, Technical Director,
UTAS Company. “With Blackfin at the heart of our patient monitoring and
diagnostics systems, we are assured a powerful, flexible processor
platform for our system designs, and our users are assured unmatched
digital signal processing performance for precise measurement of
patients’ vital signs.”
UTAS’ electrocardiographs, patient monitors, and pulse oximeters are
distinguished by their measurement precision, reliability and
affordability, and feature compact form factors and support for battery
operations to ensure ease of portability. Utilized in hospitals,
clinics, and emergency vehicles in more than twenty-five countries
around the world, UTAS’ systems are designed for use across a broad
range of patient care applications, including surgery, cardiology,
intensive care, bedside care, and patient transport.
The UM 300 patient monitor leverages a dual-core Blackfin BF561 for
centralized digital signal processing — real-time digital filtering,
preprocessing and finish processing — as well as to control the system’s
measurement virtualization capabilities and its video interface, which
enables simultaneous viewing of up to eight real-time waveforms via a
high-resolution colour display.
Blackfin BF561 is a symmetric multiprocessing configuration of two
Blackfin cores, each of which is capable of operating at up to 600
MHz/1200 MMACS with 2.6 Mb of on-chip SRAM memory. Extremely high
bandwidth is provided by the 32-bit external port and dual 16-channel
DMA controllers. With two Blackfin cores integrated within the BF561
architecture, UTAS was afforded significant space savings which further
helped to minimize design complexity and realize the UM 300’s compact
form factor.
The Blackfin BF561 features on-chip, application-tuned peripherals
that provide direct connectivity to an ADI AD7190 sigma-delta
analogue-to-digital converter (ADC) and AD7689 PulSAR ADC within the UM
300. The system also utilizes ADI AD8605 single-supply operational
amplifiers, AD8220 junction field effect transistor (JFET) input
instrument amplifiers, an ADP3335 precision voltage regulator, and an
ADuM2401 iCoupler quad-channel digital isolator, comprising a seamlessly
interconnected, high-performance component platform.
Blackfin processors are equipped with a range of innovative
architectural features that reduce their power consumption at both the
processor level and the system level, including a self contained dynamic
power management scheme whereby the operating frequency and voltage can
be independently manipulated to meet the performance requirements of the
algorithm currently being executed.
With power consumption starting as low as 0.15 mW/MMAC at 0.8 V,
Blackfin’s low-power features enabled UTAS’ system designers to maximize
the UM 300’s battery life, which is a critical factor for enabling
portable operation.
“Medical equipment developers employ some of the most stringent
standards in the electronics industry when selecting the components that
will underpin their systems,” said Colin Duggan, product line director,
GPDSP division, Analog Devices. “UTAS’ new UM 300 patient monitor is
just the latest example of how Analog Devices is delivering high
performance, feature-rich signal processing technology to enable
advanced medical systems designs.”
Bookmark this page